The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO 2023 | Clinical significance of high-count MBL versus low-count MBL
Paolo Ghia, MD, Università Vita-Salute San Raffaele, Milan, Italy, talks on the diagnosis and management of patients with monoclonal B-cell lymphocytosis (MBL) and comments on the clinical significance of high-count MBL versus low-count MBL. This interview took place at the Eleventh Annual Meeting of the Society of Hematologic Oncology (SOHO 2023) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
